Open house Arzneimittelrabattverträge Piribedil, ATC N04BC08
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Piribedil, ATC N04BC08
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No guaranteed revenue; agreements are discount contracts without purchase obligation.
Open-house model is not subject to procurement law, which may cause legal uncertainty for some bidders.
Submission deadline in 8 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Oct 2026
- Non-exclusive discount agreements for the active substance Piribedil (ATC N04BC08) according to §130a Abs. 8 SGB V.
- Contracts are identical and not individually negotiable.
Show full summary
Open-house model for non-exclusive discount agreements on Piribedil (ATC N04BC08) with AOK Bayern. Contracts can be concluded at any time until 05.09.2026, with earliest start 01.11.2024 and end 31.10.2026. No selection procedure; all eligible pharmaceutical companies can join. Estimated value not disclosed.
Risks
No guaranteed revenue; agreements are discount contracts without purchase obligation.
Open-house model is not subject to procurement law, which may cause legal uncertainty for some bidders.
Submission deadline in 8 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Eligibility
- Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible.
Administrative
- Submission of a signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
- Signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be submitted.
Requirements may be incomplete.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house Arzneimittelrabattverträge Piribedil, ATC N04BC08
Non-exclusive discount agreements for Piribedil (ATC N04BC08) with AOK Bayern. Open-house model, no competition, all eligible pharmaceutical firms can participate. Contracts run from 01.11.2024 to 31.10.2026. Submission possible until 05.09.2026.
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung
Show original TED data
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 16 Sep 2024
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 557188-2024
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No guaranteed revenue; agreements are discount contracts without purchase obligation.
Open-house model is not subject to procurement law, which may cause legal uncertainty for some bidders.
Submission deadline in 8 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications